Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,815
archived clinical trials in
Parkinsons Disease

Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated:  12/31/1969
Neurology Consultants of Dallas, PA
mi
from
Dallas, TX
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated: 12/31/1969
Neurology Consultants of Dallas, PA
mi
from
Dallas, TX
Click here to add this to my saved trials
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated:  12/31/1969
Chi St. Luke'S Health Baylor College Of Medicine Medical Center
mi
from
Houston, TX
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated: 12/31/1969
Chi St. Luke'S Health Baylor College Of Medicine Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated:  12/31/1969
UZ Gent
mi
from
Gent,
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated: 12/31/1969
UZ Gent
mi
from
Gent,
Click here to add this to my saved trials
Rhythmic Entrainment in Bilingual Speakers With Dysarthria
Rhythmic Entrainment in Bilingual Speakers With Dysarthria
Status: Enrolling
Updated:  12/31/1969
Lehman College
mi
from
Bronx, NY
Rhythmic Entrainment in Bilingual Speakers With Dysarthria
Rhythmic Entrainment in Bilingual Speakers With Dysarthria
Status: Enrolling
Updated: 12/31/1969
Lehman College
mi
from
Bronx, NY
Click here to add this to my saved trials
High-intensity Group Vocal Exercise to Improve Laryngeal Function in Patients With Parkinson Disease
High-intensity Group Vocal Exercise to Improve Laryngeal Function in Patients With Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
New York University School of Medicine
mi
from
New York, NY
High-intensity Group Vocal Exercise to Improve Laryngeal Function in Patients With Parkinson Disease
High-intensity Group Vocal Exercise to Improve Laryngeal Function in Patients With Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Atomoxetine for Freezing of Gait in Parkinson's Disease
A Pilot Study of Atomoxetine for Freezing of Gait in Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Atomoxetine for Freezing of Gait in Parkinson's Disease
A Pilot Study of Atomoxetine for Freezing of Gait in Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT
Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT
Status: Enrolling
Updated:  12/31/1969
Kenneth Marek
mi
from
New Haven, CT
Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT
Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT
Status: Enrolling
Updated: 12/31/1969
Kenneth Marek
mi
from
New Haven, CT
Click here to add this to my saved trials
Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT
Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT
Status: Enrolling
Updated:  12/31/1969
Molecular Neuroimaging, LLC
mi
from
New Haven, CT
Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT
Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT
Status: Enrolling
Updated: 12/31/1969
Molecular Neuroimaging, LLC
mi
from
New Haven, CT
Click here to add this to my saved trials
Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT
Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT
Status: Enrolling
Updated:  12/31/1969
inVentiv
mi
from
The Woodlands, TX
Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT
Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT
Status: Enrolling
Updated: 12/31/1969
inVentiv
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Effects of Deep Brain Stimulation (DBS) Frequency on Neural Synchrony
Status: Enrolling
Updated:  12/31/1969
Stanford Univ Med Ctr
mi
from
Stanford, CA
Effects of Deep Brain Stimulation (DBS) Frequency on Neural Synchrony
Status: Enrolling
Updated: 12/31/1969
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
Neural and Kinematic Features of Freezing of Gait for Adaptive Neurostimulation
Neural and Kinematic Features of Freezing of Gait for Adaptive Neurostimulation
Status: Enrolling
Updated:  12/31/1969
Stanford Movement Disorders
mi
from
Palo Alto, CA
Neural and Kinematic Features of Freezing of Gait for Adaptive Neurostimulation
Neural and Kinematic Features of Freezing of Gait for Adaptive Neurostimulation
Status: Enrolling
Updated: 12/31/1969
Stanford Movement Disorders
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Feasibility and Acceptability of a Physical Activity Behavior Change Intervention for Parkinson's Disease
Feasibility and Acceptability of a Physical Activity Behavior Change Intervention for Improving Self-efficacy, Automaticity, and Physical Activity Levels in People With Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Teachers College, Columbia University
mi
from
New York, NY
Feasibility and Acceptability of a Physical Activity Behavior Change Intervention for Parkinson's Disease
Feasibility and Acceptability of a Physical Activity Behavior Change Intervention for Improving Self-efficacy, Automaticity, and Physical Activity Levels in People With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Teachers College, Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
The Effects of Auditory Cues on Gait Mechanics in Parkinson's Disease
The Effects of Auditory Cues on Gait Mechanics in Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
The Effects of Auditory Cues on Gait Mechanics in Parkinson's Disease
The Effects of Auditory Cues on Gait Mechanics in Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Cortical Stimulation to Treat Mood and Behavioral Symptoms in Parkinson's Disease Patients
Cortical Stimulation to Treat Mood and Behavioral Symptoms in Parkinson's
Status: Enrolling
Updated:  12/31/1969
UCSF Surgical Movement Disorders Center
mi
from
San Francisco, CA
Cortical Stimulation to Treat Mood and Behavioral Symptoms in Parkinson's Disease Patients
Cortical Stimulation to Treat Mood and Behavioral Symptoms in Parkinson's
Status: Enrolling
Updated: 12/31/1969
UCSF Surgical Movement Disorders Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Methylphenidate and Parkinson's Disease
Subacute Trial of Methylphenidate in Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Department of Neurology, OP-2, Oregon Health & Science University, 3181 SW Sam Jackson Park Road
mi
from
Portland, OR
Methylphenidate and Parkinson's Disease
Subacute Trial of Methylphenidate in Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Department of Neurology, OP-2, Oregon Health & Science University, 3181 SW Sam Jackson Park Road
mi
from
Portland, OR
Click here to add this to my saved trials
Low Dose Apomorphine and Parkinsonism
Does Presynaptic Dopamine Receptor Stimulation Transiently Worsen Parkinsonism?
Status: Enrolling
Updated:  12/31/1969
Department of Neurology, Oregon Health and Science University, Mail Code OP32, 3181 SW Sam Jackson Park Road
mi
from
Portland, OR
Low Dose Apomorphine and Parkinsonism
Does Presynaptic Dopamine Receptor Stimulation Transiently Worsen Parkinsonism?
Status: Enrolling
Updated: 12/31/1969
Department of Neurology, Oregon Health and Science University, Mail Code OP32, 3181 SW Sam Jackson Park Road
mi
from
Portland, OR
Click here to add this to my saved trials
Study to Characterize Acute and Chronic Directional Aspects of Deep Brain Stimulation
Directional Lead: Investigation of Rotational Current Steering, Ease of Use of Clinical Effects Map, and Therapeutic Outcomes of Deep Brain Stimulation
Status: Enrolling
Updated:  12/31/1969
Boston Scientific Clinical Research Toll-Free Number
mi
from
Valencia, CA
Study to Characterize Acute and Chronic Directional Aspects of Deep Brain Stimulation
Directional Lead: Investigation of Rotational Current Steering, Ease of Use of Clinical Effects Map, and Therapeutic Outcomes of Deep Brain Stimulation
Status: Enrolling
Updated: 12/31/1969
Boston Scientific Clinical Research Toll-Free Number
mi
from
Valencia, CA
Click here to add this to my saved trials
A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease
A Randomized, Double Blind, Placebo-controlled Crossover Study of Tolerability and Efficacy of Cannabidiol (CBD) on Tremor in Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
University of Colorado, School of Medicine
mi
from
Aurora, CO
A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease
A Randomized, Double Blind, Placebo-controlled Crossover Study of Tolerability and Efficacy of Cannabidiol (CBD) on Tremor in Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
University of Colorado, School of Medicine
mi
from
Aurora, CO
Click here to add this to my saved trials
Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease
Optimizing Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease - Phase 1
Status: Enrolling
Updated:  12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease
Optimizing Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease - Phase 1
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Kick Out Parkinson's Disease 2
Karate Intervention to Change Kinematic Outcomes in Parkinson's Disease. KICK OUT 2: A Phase Two, Randomized Trial of a Karate Intervention
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Kick Out Parkinson's Disease 2
Karate Intervention to Change Kinematic Outcomes in Parkinson's Disease. KICK OUT 2: A Phase Two, Randomized Trial of a Karate Intervention
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Parkinson's Disease Inpatient Clinical Knowledge and Management
Parkinson's Disease Inpatient Clinical Knowledge and Management
Status: Enrolling
Updated:  12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Parkinson's Disease Inpatient Clinical Knowledge and Management
Parkinson's Disease Inpatient Clinical Knowledge and Management
Status: Enrolling
Updated: 12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
A Study of the Sense of Smell in Relatives of Parkinson's Disease Patients
Screening Evaluations for Neurologic Syndromes: Olfactory Testing in Relatives of Parkinson's Disease Patients
Status: Enrolling
Updated:  12/31/1969
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
A Study of the Sense of Smell in Relatives of Parkinson's Disease Patients
Screening Evaluations for Neurologic Syndromes: Olfactory Testing in Relatives of Parkinson's Disease Patients
Status: Enrolling
Updated: 12/31/1969
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Click here to add this to my saved trials
The Study of the Impact of Disclosing Imaging Study Information to Trial Participants
Impact of Disclosure of Dopamine Transporter Imaging Studies in PD Clinical Trials
Status: Enrolling
Updated:  12/31/1969
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
The Study of the Impact of Disclosing Imaging Study Information to Trial Participants
Impact of Disclosure of Dopamine Transporter Imaging Studies in PD Clinical Trials
Status: Enrolling
Updated: 12/31/1969
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Click here to add this to my saved trials
Assessing Imaging as a Tool in Monitoring and Predicting the Progression of Parkinson Disease
Assessing the Determinants of PD Progression - Long-term Dopamine Transporter Imaging in the PRECEPT Cohort
Status: Enrolling
Updated:  12/31/1969
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Assessing Imaging as a Tool in Monitoring and Predicting the Progression of Parkinson Disease
Assessing the Determinants of PD Progression - Long-term Dopamine Transporter Imaging in the PRECEPT Cohort
Status: Enrolling
Updated: 12/31/1969
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Click here to add this to my saved trials
Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy Subjects
Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With Parkinson Disease or Alzheimer Disease and in Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy Subjects
Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With Parkinson Disease or Alzheimer Disease and in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Click here to add this to my saved trials
Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions
Status: Enrolling
Updated:  12/31/1969
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions
Status: Enrolling
Updated: 12/31/1969
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Click here to add this to my saved trials
Exercise Study For People With Parkinson's Disease
Exercise, Physical Function, and Parkinson's Disease
Status: Enrolling
Updated:  5/21/2008
Waldron's Peak Physical Therapy
mi
from
Boulder, CO
Exercise Study For People With Parkinson's Disease
Exercise, Physical Function, and Parkinson's Disease
Status: Enrolling
Updated: 5/21/2008
Waldron's Peak Physical Therapy
mi
from
Boulder, CO
Click here to add this to my saved trials
Exercise Study For People With Parkinson's Disease
Exercise, Physical Function, and Parkinson's Disease
Status: Enrolling
Updated:  5/21/2008
Penrose Hospital
mi
from
Colorado Springs, CO
Exercise Study For People With Parkinson's Disease
Exercise, Physical Function, and Parkinson's Disease
Status: Enrolling
Updated: 5/21/2008
Penrose Hospital
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Exercise Study For People With Parkinson's Disease
Exercise, Physical Function, and Parkinson's Disease
Status: Enrolling
Updated:  5/21/2008
University of Colorado at Denver and Health Sciences Center
mi
from
Denver, CO
Exercise Study For People With Parkinson's Disease
Exercise, Physical Function, and Parkinson's Disease
Status: Enrolling
Updated: 5/21/2008
University of Colorado at Denver and Health Sciences Center
mi
from
Denver, CO
Click here to add this to my saved trials
Exercise Study For People With Parkinson's Disease
Exercise, Physical Function, and Parkinson's Disease
Status: Enrolling
Updated:  5/21/2008
Carmody Recreation Center
mi
from
Lakewood, CO
Exercise Study For People With Parkinson's Disease
Exercise, Physical Function, and Parkinson's Disease
Status: Enrolling
Updated: 5/21/2008
Carmody Recreation Center
mi
from
Lakewood, CO
Click here to add this to my saved trials
Botulinum Toxin Type A (Botox) in the Management of Levodopa-Induced Peak-Dose Dyskinesias in Parkinson's Disease
Botulinum Toxin Type A (Botox) in the Management of Levodopa-Induced Peak-Dose Dyskinesias in Parkinson's Disease: A Double-Blind, Randomized, Placebo Controlled, Cross-Over Design Study
Status: Enrolling
Updated:  2/13/2009
University Neurology-Movement Disorders Clinic
mi
from
Cincinnati, OH
Botulinum Toxin Type A (Botox) in the Management of Levodopa-Induced Peak-Dose Dyskinesias in Parkinson's Disease
Botulinum Toxin Type A (Botox) in the Management of Levodopa-Induced Peak-Dose Dyskinesias in Parkinson's Disease: A Double-Blind, Randomized, Placebo Controlled, Cross-Over Design Study
Status: Enrolling
Updated: 2/13/2009
University Neurology-Movement Disorders Clinic
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Parcopa Versus Carbidopa-Levodopa in a Single Dose Cross-Over Comparison Study
COMPARISON OF ORALLY DISSOLVING LEVODOPA (PARCOPA®) TO CONVENTIONAL ORAL LEVODOPA: A SINGLE DOSE, DOUBLE-BLIND, PLACEBO CONTROLLED, CROSS-OVER TRIAL
Status: Enrolling
Updated:  3/12/2009
PDCMDC 6550 Fannin, Suite 1801
mi
from
Houston, TX
Parcopa Versus Carbidopa-Levodopa in a Single Dose Cross-Over Comparison Study
COMPARISON OF ORALLY DISSOLVING LEVODOPA (PARCOPA®) TO CONVENTIONAL ORAL LEVODOPA: A SINGLE DOSE, DOUBLE-BLIND, PLACEBO CONTROLLED, CROSS-OVER TRIAL
Status: Enrolling
Updated: 3/12/2009
PDCMDC 6550 Fannin, Suite 1801
mi
from
Houston, TX
Click here to add this to my saved trials
Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease
Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease.
Status: Enrolling
Updated:  3/12/2009
Dee Silver, MD at Coastal Neurological Medical Group, Inc
mi
from
La Jolla, CA
Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease
Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease.
Status: Enrolling
Updated: 3/12/2009
Dee Silver, MD at Coastal Neurological Medical Group, Inc
mi
from
La Jolla, CA
Click here to add this to my saved trials
Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease
Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease.
Status: Enrolling
Updated:  3/12/2009
James Tetrud, MD at The Parkinson's Institute
mi
from
Sunnyvale, CA
Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease
Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease.
Status: Enrolling
Updated: 3/12/2009
James Tetrud, MD at The Parkinson's Institute
mi
from
Sunnyvale, CA
Click here to add this to my saved trials
Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease
Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease.
Status: Enrolling
Updated:  3/12/2009
Stuart Isaacson, MD at Parkinson's Disease and Movement Disorder Center of Boca Raton
mi
from
Boca Raton, FL
Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease
Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease.
Status: Enrolling
Updated: 3/12/2009
Stuart Isaacson, MD at Parkinson's Disease and Movement Disorder Center of Boca Raton
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease
Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease.
Status: Enrolling
Updated:  3/12/2009
R. Malcolm Stewart, MD at Neurology Specialists of Dallas
mi
from
Dallas, TX
Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease
Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease.
Status: Enrolling
Updated: 3/12/2009
R. Malcolm Stewart, MD at Neurology Specialists of Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease
Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease.
Status: Enrolling
Updated:  3/12/2009
PDCMDC 6550 Fannin, Suite 1801
mi
from
Houston, TX
Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease
Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease.
Status: Enrolling
Updated: 3/12/2009
PDCMDC 6550 Fannin, Suite 1801
mi
from
Houston, TX
Click here to add this to my saved trials
Namenda (Memantine) for Non-Motor Symptoms in Parkinson's Disease
A 16 WEEK, INVESTIGATOR-INITIATED, SINGLE-CENTER, DOUBLE BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF NAMENDA® (MEMANTINE HCL) FOR NON-MOTOR SYMPTOMS IN PARKINSON'S DISEASE
Status: Enrolling
Updated:  4/30/2009
PDCMDC 6550 Fannin, Suite 1801
mi
from
Houston, TX
Namenda (Memantine) for Non-Motor Symptoms in Parkinson's Disease
A 16 WEEK, INVESTIGATOR-INITIATED, SINGLE-CENTER, DOUBLE BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF NAMENDA® (MEMANTINE HCL) FOR NON-MOTOR SYMPTOMS IN PARKINSON'S DISEASE
Status: Enrolling
Updated: 4/30/2009
PDCMDC 6550 Fannin, Suite 1801
mi
from
Houston, TX
Click here to add this to my saved trials
Retinal Function in Parkinson's Disease
Intrinsically Photosensitive Retinal Ganglion Cells in Parkinson's Disease
Status: Enrolling
Updated:  11/6/2009
Hines VA Medical Center
mi
from
Hines, IL
Retinal Function in Parkinson's Disease
Intrinsically Photosensitive Retinal Ganglion Cells in Parkinson's Disease
Status: Enrolling
Updated: 11/6/2009
Hines VA Medical Center
mi
from
Hines, IL
Click here to add this to my saved trials
Two Separate But Identical Studies Evaluating the Safety and Efficacy of ALTROPANE® in the Use of SPECT Imaging for Upper Extremity Tremor
Evaluation of the Diagnostic Accuracy and Safety of 123 I-ALTROPANE® as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes (POET-2)
Status: Enrolling
Updated:  2/2/2010
Alseres Pharmaceuticals, Inc
mi
from
Hopkinton, MA
Two Separate But Identical Studies Evaluating the Safety and Efficacy of ALTROPANE® in the Use of SPECT Imaging for Upper Extremity Tremor
Evaluation of the Diagnostic Accuracy and Safety of 123 I-ALTROPANE® as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes (POET-2)
Status: Enrolling
Updated: 2/2/2010
Alseres Pharmaceuticals, Inc
mi
from
Hopkinton, MA
Click here to add this to my saved trials
The Effects of Vitamin D and Bone Loss in Parkinson's Disease
Effect of Vitamin D3 Supplementation in Parkinson's Disease Patients - A Pilot Study
Status: Enrolling
Updated:  6/7/2010
Conemaugh Health System - John P Murtha Neuroscience and Pain Institute
mi
from
Johnstown, PA
The Effects of Vitamin D and Bone Loss in Parkinson's Disease
Effect of Vitamin D3 Supplementation in Parkinson's Disease Patients - A Pilot Study
Status: Enrolling
Updated: 6/7/2010
Conemaugh Health System - John P Murtha Neuroscience and Pain Institute
mi
from
Johnstown, PA
Click here to add this to my saved trials
Coping With Depression in Parkinson's Disease
Treating Depression in Parkinson's Disease: A New Method
Status: Enrolling
Updated:  7/20/2010
University of Medicine and Dentistry of New Jersey (UMDNJ), Robert Wood Johnson Medical School, 675 Hoes Lane, Room D-317
mi
from
Piscataway, NJ
Coping With Depression in Parkinson's Disease
Treating Depression in Parkinson's Disease: A New Method
Status: Enrolling
Updated: 7/20/2010
University of Medicine and Dentistry of New Jersey (UMDNJ), Robert Wood Johnson Medical School, 675 Hoes Lane, Room D-317
mi
from
Piscataway, NJ
Click here to add this to my saved trials
Barriers to Mental Healthcare Utilization in Parkinson's Disease
Barriers to Mental Healthcare Utilization in Parkinson's Disease
Status: Enrolling
Updated:  7/21/2010
UMDNJ-Robert Wood Johnson Medical School
mi
from
Camden, NJ
Barriers to Mental Healthcare Utilization in Parkinson's Disease
Barriers to Mental Healthcare Utilization in Parkinson's Disease
Status: Enrolling
Updated: 7/21/2010
UMDNJ-Robert Wood Johnson Medical School
mi
from
Camden, NJ
Click here to add this to my saved trials
Molecular Epidemiology of Parkinson's Disease
Status: Enrolling
Updated:  7/28/2010
Department of Neurology, Mayo Clinic
mi
from
Rochester, MN
Molecular Epidemiology of Parkinson's Disease
Status: Enrolling
Updated: 7/28/2010
Department of Neurology, Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Neuroimaging Studies of Depression in Parkinson's Disease
UK/VA Neuroimaging Studies of Depression in Parkinson's Disease
Status: Enrolling
Updated:  9/14/2010
University of Kentucky
mi
from
Lexington, KY
Neuroimaging Studies of Depression in Parkinson's Disease
UK/VA Neuroimaging Studies of Depression in Parkinson's Disease
Status: Enrolling
Updated: 9/14/2010
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's Disease
Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's Disease
Status: Enrolling
Updated:  11/10/2010
VA Long Beach Healthcare System
mi
from
Long Beach, CA
Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's Disease
Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's Disease
Status: Enrolling
Updated: 11/10/2010
VA Long Beach Healthcare System
mi
from
Long Beach, CA
Click here to add this to my saved trials
Repetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal Degeneration
Noninvasive Cortical Stimulation (rTMS) for Motor and Non-Motor Features of Progressive Supranuclear Palsy (PSP) and Corticobasal Degeneration (CBD)
Status: Enrolling
Updated:  2/14/2011
UCLA
mi
from
Los Angeles, CA
Repetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal Degeneration
Noninvasive Cortical Stimulation (rTMS) for Motor and Non-Motor Features of Progressive Supranuclear Palsy (PSP) and Corticobasal Degeneration (CBD)
Status: Enrolling
Updated: 2/14/2011
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
WiiMote Game Controller as a Device to Study Movement Disorders
WiiMote Game Controller as a Device to Study Movement Disorders
Status: Enrolling
Updated:  3/17/2011
Vanderbilt University Medical Center
mi
from
Nashville, TN
WiiMote Game Controller as a Device to Study Movement Disorders
WiiMote Game Controller as a Device to Study Movement Disorders
Status: Enrolling
Updated: 3/17/2011
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Light Therapy Treatment in Parkinson's Disease Patients With Daytime Somnolence
Effects of Bright Light Treatment on Daytime Sleepiness and Nocturnal Sleep in Patients With Parkinson's Disease
Status: Archived
Updated:  4/18/2011
Northwestern University
mi
from
Chicago, IL
Light Therapy Treatment in Parkinson's Disease Patients With Daytime Somnolence
Effects of Bright Light Treatment on Daytime Sleepiness and Nocturnal Sleep in Patients With Parkinson's Disease
Status: Archived
Updated: 4/18/2011
Northwestern University
mi
from
Chicago, IL